Katsyuba, Elena
Mottis, Adrienne
Zietak, Marika
De Franco, Francesca
van der Velpen, Vera
Gariani, Karim
Ryu, Dongryeol
Cialabrini, Lucia
Matilainen, Olli
Liscio, Paride
Giacchè, Nicola
Stokar-Regenscheit, Nadine
Legouis, David
de Seigneux, Sophie
Ivanisevic, Julijana
Raffaelli, Nadia
Schoonjans, Kristina
Pellicciari, Roberto
Auwerx, Johan
Article History
Received: 18 September 2017
Accepted: 18 September 2018
First Online: 24 October 2018
Competing interests
: J.A., R.P. and N.R. are inventors on US patent 9,708,272 (18 July, 2017), filed by TES Pharma S.r.l., Corciano, Italy. The patent covers the results obtained with the ACMSD inhibitors, TES-991 and TES-1025, described in Figs. 3–5. R.P., F.D.F., N.G. and P.L. are employed by TES Pharma.